Increasing the Effectiveness of the Diabetes Prevention Program
1 other identifier
interventional
172
1 country
1
Brief Summary
The Diabetes Prevention Program (DPP) is highly effective in promoting weight loss in overweight and obese individuals (e.g., 7% average loss of body weight), and thereby reducing the risk of developing weight-related health consequences. One-on-one DPP sessions, however, are costly and the group-delivered DPP version, the Group Lifestyle Balance program (GLB), is less effective (4% average loss of body weight). The aim of this two-arm parallel randomized controlled trial is to increase the effectiveness of the GLB by integrating habit formation techniques, namely if-then plans and their mental practice, into the program. The study will provide evidence-based data on the effectiveness of an enhanced GLB intervention in promoting weight loss and in reducing weight-related risk factors for chronic health problems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 6, 2013
CompletedFirst Posted
Study publicly available on registry
December 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedMarch 21, 2018
March 1, 2018
4.7 years
December 6, 2013
March 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent body weight loss
The primary outcome will be percent body weight loss from baseline to 3 months after the beginning of the intervention. Weight in kg.
3 months after beginning of the intervention
Secondary Outcomes (27)
Percent body weight loss
12 months
Percent body weight loss
24 months
Personal weight loss goal
3 months
Personal weight loss goal
12 months
Personal weight loss goal
24 months
- +22 more secondary outcomes
Other Outcomes (12)
Self-Report Index of Habit Strength
3 months
Self-Report Index of Habit Strength
12 months
Self-Report Index of Habit Strength
24 months
- +9 more other outcomes
Study Arms (2)
Enriched GLB
EXPERIMENTALThis arm aims to increase the effectiveness of the Group Lifestyle Balance (GLB) program by integrating habit formation techniques, namely if-then plans and their mental practice, into the program.
Standard GLB
ACTIVE COMPARATORThis arm is the standard Group Lifestyle Balance (GLB) program, which is the group version of the Diabetes Prevention Program developed by the NIH.
Interventions
Habit formation techniques, namely if-then plans and their mental practice are being added to the standard Group Lifestyle Balance program.
This arm is the standard Group Lifestyle Balance program
Eligibility Criteria
You may qualify if:
- men and women
- ages of 18 and 75
- overweight or obese (BMI 28-45 kg/m2)
- sedentary (\< 200 min/week of moderate or vigorous exercise)
- waist circumference of \>= 88cm for women and \>= 102cm for men
You may not qualify if:
- diabetes (hemoglobin A1c \< 7.0%).
- taking the medication metformin (used for treating pre-diabetes or diabetes)
- having been pregnant in the past 6 months or planning on becoming pregnant in the next 2 years
- currently undergoing treatment for cancer
- using medication that affects body weight (e.g., loop diuretics)
- being unable to participate in regular moderate physical activity
- having severe uncontrolled hypertension (\> 190/100mm Hg)
- being unable to communicate in English or French
- being diagnosed with bulimia nervosa, currently active major depression, or other severe psychiatric disease (including dementia);
- suffering from a heart attack, stroke, or heart failure within the past 6 months
- experiencing excessive weight loss (more than 10 pounds or 4.54 kilograms) in the past 3 months
- currently participating in another weight loss program
- having had bariatric surgery in the past 2 years or plans on getting it in the near future
- planning on moving away from Montreal within the next year
- having another member of one's household enrolled in the program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McGill University
Montreal, Quebec, H3A 1B1, Canada
Related Publications (3)
Knauper B, Shireen H, Carriere K, Frayn M, Ivanova E, Xu Z, Lowensteyn I, Sadikaj G, Luszczynska A, Grover S; McGill CHIP Healthy Weight Program Investigators. The effects of if-then plans on weight loss: results of the 24-month follow-up of the McGill CHIP Healthy Weight Program randomized controlled trial. Trials. 2020 Jan 7;21(1):40. doi: 10.1186/s13063-019-4014-z.
PMID: 31910891DERIVEDKnauper B, Carriere K, Frayn M, Ivanova E, Xu Z, Ames-Bull A, Islam F, Lowensteyn I, Sadikaj G, Luszczynska A, Grover S; McGill CHIP Healthy Weight Program Investigators. The Effects of If-Then Plans on Weight Loss: Results of the McGill CHIP Healthy Weight Program Randomized Controlled Trial. Obesity (Silver Spring). 2018 Aug;26(8):1285-1295. doi: 10.1002/oby.22226. Epub 2018 Jun 28.
PMID: 29956503DERIVEDKnauper B, Ivanova E, Xu Z, Chamandy M, Lowensteyn I, Joseph L, Luszczynska A, Grover S. Increasing the effectiveness of the Diabetes Prevention Program through if-then plans: study protocol for the randomized controlled trial of the McGill CHIP Healthy Weight Program. BMC Public Health. 2014 May 18;14:470. doi: 10.1186/1471-2458-14-470.
PMID: 24885388DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbel Knauper, PhD
McGill University
- STUDY DIRECTOR
Ilka Lowensteyn, PhD
McGill University
- STUDY DIRECTOR
Lawrence Joseph, PhD
McGill University
- STUDY DIRECTOR
Aleksandra Luszczynska, PhD
University of Colorado, Denver
- STUDY DIRECTOR
Steven Grover, MD
McGill University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 6, 2013
First Posted
December 11, 2013
Study Start
April 1, 2013
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
March 21, 2018
Record last verified: 2018-03